{"database": "press", "table": "releases", "rows": [["https://gooden.house.gov/press-releases?ID=CFE4B8A7-8DFB-4DB9-B115-9EA4AA58C6FC", "New Gooden Bill Cracks Down on Synthetic Kratom Products", "2026-09-24", "2026", "2026-09", "Republican", "House", "TX", "Lance Gooden", "G000589", "gooden.house.gov", "gooden", "https://gooden.house.gov/press-releases", "scraper", "WASHINGTON \u2014 Today, Congressman Lance Gooden (TX-05) announced the End Gas Station Heroin Act, legislation to protect Americans from dangerous synthetic opioids sold in gas stations and smoke shops.\n\nThe bill permanently schedules synthetic opioids and analogs sold in synthetic kratom products, commonly known as \u201cgas station heroin.\u201d It also creates a special federal enforcement mechanism to address new and emerging substances before manufacturers can evade enforcement.\n\n\u201cDangerous synthetic opioids powerful enough to fuel addiction and destroy lives should not be sitting on convenience store shelves next to snacks and energy drinks,\u201d said Rep. Gooden. \u201cMy bill permanently schedules these drugs, closes loopholes, and targets the entities putting them into our communities.\u201d\n\nThe issue has taken on renewed urgency following the deaths of two University of Mississippi students earlier this week. Synthetic kratom products were reportedly found at the scene, though authorities have not determined the official cause of death.\n\nExisting enforcement mechanisms have struggled to keep pace as new synthetic compounds enter the market across the country. The Drug Enforcement Administration has taken temporary action to schedule certain synthetic substances, but those measures are limited and do not provide a permanent framework for addressing new compounds as they emerge.\n\nThe End Gas Station Heroin Act would:\n\nPermanently schedule several dangerous synthetic opioids and analogs, including synthetic 7-OH.\n\nCreate a mechanism to treat future emerging synthetic opioids as scheduled for manufacturers and distributors, helping prevent minor molecular alterations from being used to evade enforcement.\n\nTarget manufacturers and distributors who introduce these drugs into the stream of commerce.\n\nThe bill was featured in an exclusive article by the Washington Reporter and is cosponsored by Reps. Rich McCormick (GA-07), Barry Moore (AL-01), Mariannette Miller-Meeks (IA-01), and Randy Fine (FL-06). Senator Bernie Moreno is leading the companion in the Senate.\n\nRead the bill text here.", 1, "2026-09-25T10:04:52Z", "2026-09-25T10:05:46Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://gooden.house.gov/press-releases?ID=CFE4B8A7-8DFB-4DB9-B115-9EA4AA58C6FC"], "units": {}, "query_ms": 0.8457251824438572, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}